Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Therapeutic and marketing potential expand for Cystistat

May 25, 2000

Two new series of PDE5 inhibitors claimed by Pfizer

May 19, 2000

New class of peptides useful as selective alpha1-adrenoceptor antagonists

May 18, 2000

FDA requests additional animal data for Vasomax

May 18, 2000

HCT-1026 enters phase II trials for overactive bladder

May 15, 2000

Tanabe Seiyaku patents new inhibitors of PDE5

May 15, 2000

Fujisawa's new oxazole compounds particularly useful for glomerulonephritis

May 15, 2000

Sanofi-Synthelabo designs new PDE5 inhibitors, as reported in recent patent

May 12, 2000

A-204176 may increase IUP without cardiovascular side effects according to preclinical data

May 5, 2000

Early clinical trial results in BPH suggest promise of new highly selective alpha1A blocker

May 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...